Company President and Chief Executive Yuichi Iwaki hopes to start human trials by December.
La Jolla’s MediciNova teams with Japanese partners in hunt for coronavirus vaccine
Company President and Chief Executive Yuichi Iwaki hopes to start human trials by December.